Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection. - Wikidata - wikimedia - TriplyDB

Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.

Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.

http://www.wikidata.org/entity/Q37625016

about

The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.Organ-specific innate immune responses in a mouse model of invasive candidiasis.Inhibition of filamentation can be used to treat disseminated candidiasis Dose escalation studies with caspofungin against Candida glabrata.Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials.Caspofungin disk diffusion breakpoints and quality control.In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis.Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.Identification of a new antifungal oligoacetal derivative produced by Streptomyces toxytricini against Candida albicans.

P2860

Q34290097-E2DB7BD0-6FC6-4695-9D67-6B318A382104 Q34769434-00300663-045C-4D2D-BBEC-E3A49A6E4581 Q35091490-EA9C92C5-5B27-4222-BE92-646EA67DFD05 Q36376559-A19EFB76-152C-4EF1-B920-0A22D18D8C82 Q39198615-AE874051-80A7-4856-9B84-B33E602F9F6C Q39761638-598E82A8-74E3-43B5-90E3-541F49F441A3 Q41387320-BE1D5449-3197-49EC-816B-D3EEDDF3BA56 Q42112304-F5910E21-CE03-4DD1-8438-C11A7423F9A2 Q46977087-00C4D80F-5F34-4552-BD51-AC2863894D65

P2860

Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.

http://www.wikidata.org/entity/Q37625016

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Need for early antifungal trea ...... ed Candida albicans infection.

@en

Need for early antifungal trea ...... ed Candida albicans infection.

@nl

type

label

Need for early antifungal trea ...... ed Candida albicans infection.

@en

Need for early antifungal trea ...... ed Candida albicans infection.

@nl

prefLabel

Need for early antifungal trea ...... ed Candida albicans infection.

@en

Need for early antifungal trea ...... ed Candida albicans infection.

@nl

P1433

Q37625016-F8B91B84-AD2D-40CB-BD59-1EC0B955100D

P1476

Q37625016-011F9FB3-DC15-43F2-A481-4E5782CFC221

P2093

Q37625016-1CFBF66B-EFE9-49F5-8E23-1A7E83AE39D1

P2860

Q37625016-1E56AAD3-22DD-4977-94DF-D2738F7DAECC

Q37625016-2157F855-4CC9-4DD3-8C0E-3CA4D969BD73

Q37625016-21DA2E85-7CC7-4678-82D1-E05C045FEF42

Q37625016-29B1AC42-FAEF-45D3-B95D-D4EF6CD3002D

Q37625016-4696B27E-5B06-4430-97D2-00C6F326B778

Q37625016-67CA5623-82E2-420B-AECA-6796CC364949

Q37625016-6A29092E-04A7-4C87-82F8-1D558F193917

Q37625016-75F6F78A-7323-44F3-88A8-17A21260205D

Q37625016-919BFD64-4885-4425-B4A2-CE74B9204FE0

Q37625016-9E95C94D-98AC-4A79-8831-85872997D33F

P304

Q37625016-B07A3E45-B26F-4B67-AE89-0FA38BD21DF7

P31

Q37625016-630CB8DA-97CC-43DB-9734-2E4706968FDE

P356

Q37625016-C17539F0-9868-4484-BB98-FA76B098CA5C

P407

Q37625016-1049F8C0-26EC-45C9-9E5E-872B267E8339

P433

Q37625016-47C07665-B5FB-4557-AA0A-3D5C4A2DD22A

P478

Q37625016-BD797567-CAB2-4C99-9129-CA35C9B906AD

P50

Q37625016-08C5ED69-D859-4402-BC9A-DCD863D0F2A3

P577

Q37625016-3DA54039-EAFD-446B-958A-707E5D2FA81A

P698

Q37625016-7E2F8CFD-A0AE-42FF-B1C4-7501191B8131

P921

Q37625016-FA1F8569-7AC4-4834-92F4-C96FFDEDB89D

P932

Q37625016-82DD89E4-4AD2-45FF-8054-8C542C219A43

P356

AAC.48.12.4911-4914.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

Need for early antifungal trea ...... ted Candida albicans infection

@en

P2093

Frank C Odds

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis

Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Current serological and molecular methods in the diagnosis of systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies.

Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.

Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.

Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis.

P304

4911-4914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.12.4911-4914.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Donna M MacCallum

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15561880

http://www.w3.org/2001/XMLSchema#string

P921

diagnostic test

P932

529222

http://www.w3.org/2001/XMLSchema#string